Emmanuelle Charpentier, PhD, and Jennifer Doudna, PhD, who pioneered the 
site-specific CRISPR gene-editing technology that has revolutionized cancer 
research and treatment, were awarded the 2020 Nobel Prize in Chemistry. Many 
CRISPR-based therapies are already in human testing, with gene-edited T cells 
for blood cancers and solid tumors leading the way.